Deep Vein Thrombosis

Clinical Trial Finder

Many patients with deep vein thrombosis are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Thrombin Generation in Crohn's Disease

Conditions:   Crohn Disease;   Blood Clot;   Thrombosis
Sponsors:   University of Sao Paulo General Hospital;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified May 2015

Comparison of Topical and Infusion Tranexamic Acid After Total Knee Arthroplasty

Condition:   Osteoarthritis, Knee
Interventions:   Drug: Tranexamic Acid 5%,5ml/amp;   Drug: Tranexamic Acid 5%,5ml/amp;   Drug: rivaroxaban (10mg);   Drug: 0.9% Normal Saline;   Drug: 0.9% Normal Saline
Sponsor:   Chang Gung Memorial Hospital
Not yet recruiting - verified May 2015

Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico

Conditions:   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Apixaban
Sponsor:   Bristol-Myers Squibb
Not yet recruiting - verified May 2015

Safety and Efficacy Study of Apixaban to Prevent Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG Asparaginase

Conditions:   Lymphoma;   Acute Lymphoblastic Leukemia
Interventions:   Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
Sponsor:   Bristol-Myers Squibb
Recruiting - verified April 2015

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery

Conditions:   Anemia;   Cardiovascular Disease
Interventions:   Drug: EPO;   Drug: Feraheme
Sponsors:   University of Texas Southwestern Medical Center;   AMAG Pharmaceuticals, Inc.
Recruiting - verified January 2015

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified May 2015

The SENTRY Clinical Study

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Device: SENTRY IVC Filter
Sponsor:   Novate Medical
Recruiting - verified May 2015

Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin

Conditions:   Venous Thromboembolic Disease;   Deep Vein Thrombosis;   Pulmonary Embolism
Interventions:   Drug: 5000 Units unfractionated Heparin Q 8 hours;   Drug: 30mg enoxaparin Q12 hours
Sponsor:   Scripps Health
Completed - verified May 2015

Left Rule, D-Dimer Measurement and Complete Ultrasonography to Rule Out Deep Vein Thrombosis During Pregnancy.

Conditions:   Pregnancy;   Deep Vein Thrombosis
Intervention:   Other: Left rule, D-dimer measurement and complete ultrasonography in pregnant women.
Sponsors:   Marc Righini;   University Hospital, Brest;   The Ottawa Hospital
Recruiting - verified May 2015

Point of Care Ultrasound (US) Versus Detailed Radiology US for Deep Vein Thrombosis (DVT)

Sponsor:   University of Missouri-Columbia
Withdrawn - verified May 2015

Ruling Out Pulmonary Embolism During Pregnancy:a Multicenter Outcome Study

Conditions:   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention:   Other: Pregnant patients with suspected PE will undergo a strategy based on clinical probability assessment, D-dimer, lower limb vein ultrasonography and MSCT.
Sponsors:   University Hospital, Geneva;   Swiss National Science Foundation
Recruiting - verified May 2015

Randomized Controlled Trial of Anticoagulation vs. Placebo for a First Symptomatic Isolated Distal Deep-vein Thrombosis (IDDVT)

Condition:   Distal (Calf) Deep-vein Thrombosis
Interventions:   Drug: nadroparine calcium;   Drug: Placebo
Sponsors:   University Hospital, Geneva;   Swiss National Science Foundation;   Ministry of Health, France;   Lady Davis Institute;   Canadian Institutes of Health Research  (CIHR)
Recruiting - verified May 2015

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Conditions:   Venous Thrombosis;   Pulmonary Embolism
Intervention:   Drug: Tinzaparin
Sponsors:   St. Joseph's Healthcare Hamilton;   Heart and Stroke Foundation of Ontario;   LEO Pharma
Recruiting - verified May 2015

Get CardioSmart

You're Invited